Eyenovia Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Eyenovia Inc (EYEN) Tops Q2 EPS by 9c
August 14, 2018 6:33 AM EDTEyenovia Inc (NASDAQ: EYEN) reported Q2 EPS of ($0.33), $0.09 better than the analyst estimate of ($0.42).
Dr. Sean Ianchulev, Eyenovias Chief Executive Officer and Chief Medical Officer commented, In the first half of 2018, we further validated our novel therapeutic platform with compelling IOP... More
